By Jim Stafford
Copyright © 2018, The Oklahoma Publishing Co.
In a room filled with blood donors at the Oklahoma Blood Institute’s (OBI) donation center, Jennifer Chain, Ph.D., pronounces some words that don’t easily roll off the tongue. Allogeneic. Autologous. Apheresis.
Chain’s audience includes me and a pair of colleagues from the Oklahoma Center for the Advancement of Science and Technology (OCAST). We are visiting OBI to learn about its cellular therapy program in which it is developing cell-based products for research and clinical use.
We learn that allogeneic is a blood donation from one person that can be used in different individuals. Autologous is a se